تقرير
أعرض في EDS

A Single-Center Study of Patients With Synchronous Primary Malignancy: A Case Series.

التفاصيل البيبلوغرافية
العنوان: A Single-Center Study of Patients With Synchronous Primary Malignancy: A Case Series.
المؤلفون: Alsulaimani AI; Medicine, Taif University, Taif, SAU., Alkhaldi LM; Medicine, Taif University, Taif, SAU., AlTawairqi SA; General Surgery, Alhada Military Hospital, Taif, SAU., Khurshid A; General Surgery, Alhada Military Hospital, Taif, SAU., Abdulaziz HA; General Surgery, Alhada Military Hospital, Taif, SAU., Alotaibi AG; General Surgery, Alhada Military Hospital, Taif, SAU., Alotaibi HO; Surgical Oncology, Mcgill University, Montreal, CAN.; Surgery, Taif University, Taif, SAU.
المصدر: Cureus [Cureus] 2022 Dec 22; Vol. 14 (12), pp. e32839. Date of Electronic Publication: 2022 Dec 22 (Print Publication: 2022).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Multiple primary malignant tumors (MPMT) can be defined as more than two different tumors synchronously or metachronously forming in the same organ or different organs. The incidence of MPMTs varies dramatically between antemortem and postmortem examinations, becoming a serious medical issue. Evidence shows that the overall incidence of MPMTs is between 2.4% and 17%. Double primary malignancy (DPM) is considered the most common type of MPMT. In this case series, we present three cases of MPMT. The first case involved the colon and the breast, the second case involved the colon and the kidney, and the third case involved rectum and kidney.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Alsulaimani et al.)
References: Int J Clin Oncol. 2003 Jun;8(3):162-7. (PMID: 12851840)
BJU Int. 2006 Apr;97(4):698-702. (PMID: 16536756)
Int J Mol Sci. 2021 Jan 07;22(2):. (PMID: 33430305)
Int J Urol. 2004 May;11(5):269-75. (PMID: 15147541)
Genet Mol Res. 2014 Mar 12;13(4):9271-84. (PMID: 24682981)
Eur J Cancer. 1997 Oct;33(11):1829-34. (PMID: 9470841)
Ann Oncol. 2004 May;15(5):843-4. (PMID: 15111359)
World J Oncol. 2021 Feb;12(1):20-27. (PMID: 33738002)
Hepatogastroenterology. 1994 Oct;41(5):409-12. (PMID: 7851846)
Rev Urol. 2003 Winter;5(1):49-53. (PMID: 16985618)
J Cancer. 2018 Jul 16;9(16):2795-2801. (PMID: 30123347)
Int Urol Nephrol. 1995;27(1):1-8. (PMID: 7615361)
BMC Cancer. 2014 Apr 18;14:272. (PMID: 24742063)
J Med Case Rep. 2011 Apr 04;5:134. (PMID: 21463521)
Kidney Int. 2002 May;61(5):1806-13. (PMID: 11967031)
Scand J Surg. 2004;93(2):150-5. (PMID: 15285568)
Ann Coloproctol. 2014 Feb;30(1):18-22. (PMID: 24639966)
Langenbecks Arch Surg. 2010 Apr;395(4):359-64. (PMID: 19763603)
BMJ Case Rep. 2013 Jul 10;2013:. (PMID: 23845673)
Kaohsiung J Med Sci. 2006 Nov;22(11):547-53. (PMID: 17110343)
Bull Cancer. 1992;79(7):689-96. (PMID: 1467595)
F1000Res. 2017 Aug 17;6:1502. (PMID: 29333235)
Int J Surg Case Rep. 2010;1(2):16-8. (PMID: 22096666)
Arch Intern Med. 2008 May 12;168(9):1003-9. (PMID: 18474765)
Eur Urol. 2008 Dec;54(6):1226-36. (PMID: 18715695)
Int J Colorectal Dis. 2009 Apr;24(4):369-75. (PMID: 18797888)
ESMO Open. 2017 May 2;2(2):e000172. (PMID: 28761745)
Ann Surg Oncol. 2012 Jan;19(1):242-8. (PMID: 21701928)
Am J Hum Genet. 2003 May;72(5):1308-14. (PMID: 12690581)
World J Urol. 2006 Aug;24(3):255-66. (PMID: 16479388)
فهرسة مساهمة: Keywords: malignancy; multiple; neoplasms; oncosurgery; synchronous
تواريخ الأحداث: Date Created: 20230125 Latest Revision: 20230201
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9867554
DOI: 10.7759/cureus.32839
PMID: 36694511
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.32839